Check Influx Healthtech IPO Allotment Status online using PAN or Application No. Track refund dates, Demat credit, listing date & GMP updates.
📅 Influx Healthtech IPO Important Dates
| Event | Date |
|---|---|
| IPO Type | SME |
| IPO Method | Book Building |
| IPO Open Date | 18 June 2025 (Wednesday) |
| IPO Close Date | 20 June 2025 (Friday) |
| Basis of Allotment(Allotment Finalisation) | 23 June 2025 (Monday) |
| Initiation of Refunds | 24 June 2025 (Tuesday) |
| Shares Credited to Demat | 24 June 2025 (Tuesday) |
| IPO Listing Date | 25 June 2025 (Wednesday) |
| Listing Exchange | NSE |
🔎 How to Check Influx Healthtech IPO Allotment Status
The allotment status for Influx Healthtech IPO will be available once finalized by the registrar. Investors can check their allotment status by visiting the official portal of the registrar or through NSE links by using your PAN, Application Number, or DP/Client ID.
You can check your allotment status through any of the following methods:
📌 1. Through Registrar (Maashitla)
- Visit the registrar’s official website: Maashitla Securities Private Limited
- Select “Influx Healthtech IPO” from the dropdown.
- Enter any of the following PAN / Application Number / DP Client ID.
- Click on “Submit” to view your allotment status.
📌 2. Through NSE Website
- Visit: 🔗NSE Allotment Status
- Select Equity & SME IPO bid details and then “INFLUX“
- Enter Application No. and PAN.
- Click Submit.
❓FAQ’s
To Stay Updated with IPO Allotment Status refer IPO Allotment Status 2025
🏢 Company Overview
Influx Healthtech Limited is a Mumbai-based healthcare company specializing in contract development and manufacturing (CDMO) services. Established in 2020, the company has rapidly built a reputation for delivering high-quality manufacturing solutions across multiple sectors, including nutraceuticals, cosmetics, ayurvedic products, veterinary supplements, homecare products, and pharmaceuticals.
The company operates three state-of-the-art manufacturing facilities in Thane, Maharashtra, covering areas of approximately 9,676 sq. ft., 13,000 sq. ft., and 14,000 sq. ft., respectively. These facilities are equipped with advanced machinery and staffed by a skilled workforce, supported by a dedicated quality control department. All manufacturing units are certified with international quality standards such as GMP (Good Manufacturing Practices), HACCP, ISO 22000, and Halal certifications, ensuring compliance with global safety and regulatory norms.
Influx’s wide-ranging manufacturing capabilities include dietary and nutritional supplements, ayurvedic and herbal formulations, cosmetics, veterinary feed supplements, homecare products, and finished dosage forms such as tablets, capsules, and injectables. The company also handles the production of Active Pharmaceutical Ingredients (APIs).